Paul Tebbey, Ph.D., MBA

scientific strategy

Paul Tebbey, Ph.D., MBA

scientific strategy

Paul Tebbey, Ph.D., MBA

scientific strategy

Paul Tebbey, Ph.D., MBA

scientific strategy

Paul Tebbey, Ph.D., MBA

scientific strategy

Biography

Dr. Tebbey received his bachelor’s degree in Applied Biological Sciences with honors from the University of the West of England (1989). He then obtained his PhD from East Carolina University (1993) which focused on identification of arachidonic acid as a pluripotent regulator of gene expression. Dr. Tebbey also completed a postdoctoral fellowship at Vanderbilt University investigating the genetic basis of non-insulin-dependent diabetes mellitus (1995) and his MBA at Rochester Institute of Technology in Marketing (2002). Since then, he has served as an executive leader with broad therapeutic category expertise at several companies, most recently as Chief Operating Officer of Elusys Therapeutics and Senior Vice President of Product Development at NightHawk Biosciences.

Dr. Paul Tebbey is a co-founder and member of the Board of Directors at Radyus Research, bringing with him over 30 years of pharmaceutical development and strategic leadership across biotechnology and pharmaceutical sectors. Dr. Tebbey’s executive management roles as Senior VP of Product Development and Portfolio Strategy at Heat Biologics, Inc., VP of Oncology US Medical Affairs at Abbvie, Head of International Marketing Services at Baxter, and Managing Director of Kolabri Consulting, are invaluable to our work at Radyus.

He has deep research, development, and commercial launch experiences including novel mAbs (STELARA®, REMICADE® & HUMIRA®), complex vaccines (PREVNAR®, & viagenpumatucel-L), biosimilars, and oncolytic small molecules (VENCLEXTA®). Dr. Tebbey received a Ph.D., in Microbiology & Immunology from East Carolina University School of Medicine, where his research focused on T lymphocyte cell signaling.  

He holds three patents for new therapeutic treatments and has published over 40 peer-reviewed articles on a wide variety of topics including immunology, infectious diseases, clinical trial design, pharmaceutical strategy, planning, and brand success. Utilizing his extensive industry knowledge and experience, Dr. Tebbey seeks to advance the development of innovative novel strategies against disease with Radyus Research.

“I’m a disease’s worst enemy. You can trust me, I’m a doctor.”  

Work History

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

Education

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

I am passionate about advancing the development of novel strategies against disease." --Dr. Paul Tebbey